Eversheds Sutherland has advised the European Innovation Council Fund (the EIC Fund) in connection with Cellevate AB raising SEK 39 million in seed financing to accelerate their global commercial launch. The financing round was led by Industrifonden in syndication with the EIC Fund and OnSight Ventures.
Cellevate is an innovative biotech company that develops the next generation of cell culture systems designed to revolutionize biomanufacturing.
This transaction is in line with the long-term collaboration agreement between Eversheds Sutherland and the European Innovation Council Fund, in which the European Investment Bank (EIB) acts as investment advisor to the fund.
Eversheds Sutherland's team consisted of Gabriel Albemark and Therése Berg.
The materials on the Eversheds Sutherland website are for general information purposes only and do not constitute legal advice. While reasonable care is taken to ensure accuracy, the materials may not reflect the most current legal developments. Eversheds Sutherland disclaims liability for actions taken based on the materials. Always consult a qualified lawyer for specific legal matters. To view the full disclaimer, see our Terms and Conditions or Disclaimer section in the footer.